Functional Electrical Stimulation for Hemiplegic Cerebral Palsy



Status:Completed
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:6 - 17
Updated:1/1/2014
Start Date:March 2013
End Date:May 2014
Contact:Amy F Bailes, PT, MS
Email:amy.bailes@cchmc.org
Phone:5138030782

Use our guide to learn which trials are right for you!

Effects of Functional Electrical Stimulation Neuroprosthesis in Children With Hemiplegic Cerebral Palsy

The purpose of this study is to evaluate how a functional electrical stimulation (FES)
device worn on the lower leg effects how children (ages 6-17 years) with hemiplegic cerebral
palsy walk and perform other functional activities.

The investigators expect to find that wearing the functional electrical stimulation device
will improve walking and other functional activities of children with hemiplegic cerebral
palsy. Participants will be trained in use of the device and will be required to wear it
daily for 3 months. Each participant will be evaluated before beginning the intervention and
after completing the intervention. This study will provide important information regarding
the benefits of this treatment intervention in children with hemiplegic cerebral palsy.


Inclusion Criteria:

- Diagnosis of hemiplegic Cerebral Palsy

- Gross Motor Function Classification System (GMFCS) I or II

- Age 6-17 years inclusive

- Demonstrate foot drop during gait without wearing ankle foot orthosis

- Tolerance to neuroprosthesis stimulation

- Physician referral to participate in intervention

- Passive dorsiflexion to at least neutral with knee extended

- Available to travel to and from study visits

- Ability to follow instructions and cooperate with study protocol

- Caregiver reads and understands English

- Exclusion criteria:

- Any metal implants containing electrical circuitry

- Continuous regular use of neuroprosthesis stimulation previous to study enrollment

- Previous orthopaedic procedure involving tibialis anterior muscle at any time

- Previous orthopaedic procedure to affected limb in the last year

- Botulinum toxin administered within the past 3 months, or plans for such treatment
during the course of the study

- Any condition that PI feels would limit ambulatory progress (e.g. arthritis,
uncontrolled seizures)
We found this trial at
1
site
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
 1-513-636-4200 
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials